Google+ Facebook Twitter Twitter

Under the microscope: Prime editing

This month: Prime editing

What is prime editing?

The latest gene editing technology, which it is claimed expands the “genetic toolbox” for more precisely creating disease models and correcting genetic problems.

Nope. That doesn’t ring any bells.

Don’t worry – it’s very new. In fact, a recent paper by Medical College of Georgia scientists is only the second published study in the use of prime editing in a mouse model.

What did their study reveal?

They reported that prime editing and traditional CRISPR both successfully shut down a gene involved in the differentiation of smooth muscle cells, which helps give strength and movement to organs and blood vessels.

So it’s as good as CRISPR?

Prime editing snips only a single strand of the double-stranded DNA. CRISPR makes double-strand cuts, which can be lethal to cells, and produces unintended edits at both the work site as well as randomly across the genome.

What do the authors say?

Dr Joseph Miano, genome editor and molecular biologist, said: “Prime editing is a less intrusive cut of the DNA. It’s very clean. This is what we want: No detectable indels, no collateral damage. The bottom line is that unintended consequences are much less and it’s actually less complicated to use.” 

How much does he know about CRISPR?

Quite a bit – Miano was among the first wave of scientists to use CRISPR to alter the mouse genome in 2013.

Can I read more?

Yep, here’s a link to their full paper online –

Image credit | iStock

Related Articles

Unintended consequences

Computational biologist Gregorio Alanis- Lobato highlights the need for greater awareness of and further research into the effects of CRISPR-Cas9 genome editing.

The evolution of quality assessment

In 2011, UK NEQAS Cellular Pathology Technique (CPT) carried out tests across four schemes – it now covers 12 schemes with two in the pipeline. We hear from Chantell Hodgson, UK NEQAS CPT Scheme Manager.

Blurring boundaries: Ethics and artificial intelligence

With artificial intelligence becoming ever more prominent in biomedical labs and research, biomedical scientist turned ethicist Sarah E Carter looks at the pressing issues.

Tech news: April

This month's top tech news stories